Suspicion of ASNSD is typically prompted by recognition of the phenotype in newborns and subsequently confirmed by whole‐exome DNA sequencing that identified mutations in the ASNS gene. This evidence concerns the gene ASNS and congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome.